<DOC>
	<DOCNO>NCT01255813</DOCNO>
	<brief_summary>The purpose propose clinical study evaluate use implant Neurostimulator provide Sphenopalatine Ganglion ( SPG ) stimulation management pain associate cluster headache .</brief_summary>
	<brief_title>Sphenopalatine Ganglion Stimulation Acute Treatment Cluster Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<criteria>Age 18 65 year old ( inclusive ) . Subject diagnose chronic cluster headache accord 2004 International Headache Society ( IHS ) criteria 3.1.2 . Subject report minimum 4 cluster headache per week . Subject report dissatisfaction current cluster headache treatment ( Criterion include preventive abortive therapy per Investigator 's standard care . Reasons dissatisfaction exist headache therapy may include failure therapy , contraindication , side effect therapy , patient refusal available therapy ) Subject able distinguish cluster headache headache ( i.e. , tensiontype headache ) . Subject ability read comprehend , reliably record information require Protocol . Subject able provide write informed consent prior participation study . Subject change type dosage prophylactic headache medication &lt; one ( 1 ) month prior study enrollment Subject undergone facial surgery area pterygopalatine fossa zygomaticomaxillary buttress ipsilateral plan implant site within last four ( 4 ) month . Subject active oral dental abscess . Subject treat radiation facial region within last six ( 6 ) month . Subject diagnose major infectious process osteomyelitis , primary secondary malignancy involve face active require treatment past six ( 6 ) month . Subject significant pain problem might confound study assessment opinion Investigator . Subject woman childbearing age pregnant , nursing , use contraception . Subject currently participate participate last month another clinical study subject , , expose investigational noninvestigational drug device . Subject felt risk noncompliance ( e.g. , complete diary maintain stable headache medicine regimen ) Investigator 's opinion . Subject previous lesional radiofrequency ablation ipsilateral sphenopalatine ganglion ( SPG ) . Subject block ipsilateral SPG last three ( 3 ) month . Subject undergone botulinum toxin injection head and/or neck last three ( 3 ) month . Subject require pacemaker/defibrillator implantable device sense amplifier . Subject history bleeding disorder coagulopathy unable discontinue anticoagulation , antiplatelet , GP IIb IIIa inhibitor medication preparation implantation procedure . Subject suitable study reason judgment Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Chronic Cluster Headache</keyword>
</DOC>